SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001193125-24-083388
Filing Date
2024-04-01
Accepted
2024-04-01 16:15:34
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-01

Document Format Files

Seq Description Document Type Size
1 NT 10-K d796703dnt10k.htm NT 10-K 26348
  Complete submission text file 0001193125-24-083388.txt   27530
Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Filer) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 001-38130 | Film No.: 24809473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)